hsa-mir-602: Hsa-mir-602 is a microRNA that has been identified in various studies. It is a member of miRNA cluster 3 and has been associated with different signaling pathways such as MAPK, insulin, and calcium signaling pathways [PMC4464413]. In the HMDD database, hsa-mir-602 is listed as one of the 10 miRNAs associated with Group 1 [PMC9877296]. In the GSE51674 dataset, which compares kidney tissues of healthy individuals with kidney tissue samples of DN patients, hsa-mir-602 is one of the differentially expressed miRNAs [PMC8616647]. It has also been detected in PAXgene blood samples but not in EDTA blood samples [PMC4658123]. In another study comparing kidney tissue samples of patients with membranous nephropathy and healthy controls, hsa-mir-602 was found to be differentially expressed [PMC8610666]. Furthermore, hsa-mir-602 was found to be one of the five prognostic miRNAs in the Mesenchymal subtype [PMC3917617]. It has also been identified as one of the miRNAs that show different expression levels between GV and MII oocytes [PMC4919285]. Additionally, hsa-mir-602 has been reported to target SARS-CoV-2 genome and was upregulated by enoxacin treatment [PMC8119475]. Overall, hsa-mir-602 plays a role in various biological processes and has potential implications in disease conditions.